Effects of Treatment With ENF (Electro Neuro Feedback) in the Reduction of Post-surgical Hematoma in Patients Undergoing Hip Replacement: Evaluation With Ultrasound Method

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05196321

Enrollment

Registered

2022-01-19

Start date

2021-11-11

Completion date

2023-07-20

Last updated

2022-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-surgical Hematoma, Hip Replacement , Surgery

Brief summary

The study evaluates patients with clinical evidence of post-surgical hematoma / seroma after hip replacement surgery. These patients will undergo ultrasound evaluation in the 4th (+/- 2) day post surgery, in which triaxial parameters of the hematoma will be measured. This evaluation will then be repeated after 5 treatment sessions with ENF (Electro Neuro Feedback). The patient will then be subjected to evaluation scales that allow to evaluate the subjective improvement of the state of well-being after treatment ENF (Electro Neuro Feedback) generates waveforms that change automatically when the impedance of the skin changes according to a compensation algorithm, i.e. according to Feedback (Feedback). T

Interventions

OTHERsessions with ENF (Electro Neuro Feedback).

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

35 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Gender: male and female * Age: 35-85 years include * Entry into the hospital rehabilitation program lasting at least 5 days following hip replacement surgery * Absence in history of neurological or psychiatric disorders. * Signature of the Informed Consent and consent to collaborate in all the procedures of the study

Exclusion criteria

* Presence of severe neurological / psychiatric pathologies * to sign the Informed Consense * of serious cardiological pathologies that can compromise patient safety * of Pace Maker or spinal cord stimulators or other subcutaneous electronic instruments * of active tumors in the treatment area

Design outcomes

Primary

Measure	Time frame
change of post-surgical hematoma measured by ultrasound method with triaxial measurement after 5 treatment sessions with ENF	at the end of Cycle 5 ( every cycle during 5 days)

Countries

Italy

Contacts

Primary Contactcristina beretta

cristina.beretta@grupposandonato.it0039024878521

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026